Andy Knight @AndyKnightMD Twitter profile

Pinned Tweet

Andy Knight

9 months

I matched at @DanaFarber for Heme/Onc fellowship!!! I cannot express how excited I am! Thank you to my incredible mentors and everyone who supported me through this process. I can't wait for this next chapter. @KarapetLilit @jmkirkwood @YanaNajjarMD @LenAppleman @jasonlukemd

25

6

446

Last Seen Profiles

@starutozie

@asa_shee

@kmix_wotaku

@asa_shee

@kkayoh_

@Morningstar_VC

@Ciag_Misr777

@Hamsii615

@Abdalezem1

@reelman01

@MolinaPolicia

@ScamSniffers

@BilionaireMayor

@DanoninoFM

@grafa_kui

@w4_gf

@JakeScottZone

@MrPruneda

@BodyBackUp

@ecornell_online

@25kimi1

@0825media

@A_S_D_P

@bokeplokalmalam

@stw_pdg

@davidfrum

@xox_rom

@heykayadams

@smejim_it

@domi_twr

@yuim_l

@bokeplokalmalam

@tomdxv791

@Br_____rd

@reelman01

@bokeplokalmalam

Andy Knight

@AndyKnightMD

1 year

Highlight of #ASCO23 to have such incredible questions and amazing support. Thank you to everyone who came by my poster. #Melanoma #Immunotherapy

3

5

42

Andy Knight

@AndyKnightMD

1 year

Excited to be at #ASCO23 for the first time! Can't wait to connect with fellow researchers and witness their groundbreaking work 🌟

1

3

41

Andy Knight

@AndyKnightMD

1 year

Excited to share that I will be presenting our work on immune-related adverse events in melanoma at #ASCO2023 . Thank you to @jmkirkwood , @KarapetLilit and @UPMCHillmanCC for the ongoing support and guidance.

2

4

25

Andy Knight

@AndyKnightMD

2 years

Happy to present our work on immune related adverse events during adjuvant treatment of melanoma. Great to meet so many incredible investigators at #SITC2022 . Thanks to everyone at @UPMCHillmanCC and @PittTweet that made this possible. @PittIMChiefs #Melanoma #irAEs

0

2

21

Andy Knight

@AndyKnightMD

1 year

Thank you to @KarapetLilit from @MoffittNews for your incredible mentorship and support! So great to see you at #ASCO2023

1

2

16

Andy Knight

@AndyKnightMD

2 years

Immunotherapy has significantly improved outcomes for patients with melanoma. Our review in @Cancers_MDPI explores the recent history of IO development and novel approaches for IO refractory patients. Summary 🧵 #mdpicancers #melanoma #immunotherapy

Immunotherapy in Melanoma: Recent Advances and Future Directions

The use of immunotherapy in the treatment of advanced and high-risk melanoma has led to a striking improvement in outcomes. Although the incidence of melanoma has continued to rise, median survival...

www.mdpi.com

2

14

Andy Knight

@AndyKnightMD

2 years

Excited to be heading to #SITC2022 for the first time! Come say hi at poster 1267 to learn more about the effect of immunosuppression during adjuvant anti-PD-1 treatment for stage III melanoma #Melanoma #Immunotherapy

2

14

Andy Knight

@AndyKnightMD

2 years

Great work from my co-residents! Thank you @PittDeptofMed for the opportunity to present our research on the impact of immunosuppression for patients with melanoma treated with anti-PD1 therapy. Huge thanks to Dr. John Kirkwood and @KarapetLilit for making this possible. @PittGIM

2

14

Andy Knight

@AndyKnightMD

2 years

Check out our work in @Cancers_MDPI to better predict melanoma recurrence using a novel 12-gene risk score. So fortunate to be collaborating with this amazing team at @UPMCHillmanCC and @MoffittNews led by @KarapetLilit #melanoma #oncology

Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous...

We sought to develop a sentinel lymph node gene expression signature score predictive of disease recurrence in patients with cutaneous melanoma. Gene expression profiling was performed on SLN...

www.mdpi.com

1

4

10

Andy Knight

@AndyKnightMD

1 year

Congratulations to everyone participating in #Match2023 ! Can't wait to meet all the new #UPMC residents

0

1

10

Andy Knight

@AndyKnightMD

1 year

Thank you to AIM for this important opportunity to discuss changes in the field of #Melanoma treatment with our patients. I will be discussing Non-invasive Detection and Gene Expression Profiling. @UPMCHillmanCC

AIM at Melanoma Foundation

@AIMatMelanoma

1 year

UPMC Hillman Cancer Center | April 1, 2023

0

2

0

3

9

Andy Knight

@AndyKnightMD

1 year

Starting of #ASCO23 day 2 with @JZarkaMD and @PittHemeOnc fellows. Great talk by @ADesaiMD about the importance of social media in oncology

Jabra Zarka

@JZarkaMD

1 year

Happening now! @ADesaiMD starting our Day 2 @ASCO with advise on how to use social media to navigate the annual meeting! #ASCO23 @OncoAlert @HemOncFellows @AndreaAnampaG @cissamathias

1

6

28

0

2

8

Andy Knight

@AndyKnightMD

1 year

Cards superstar @gautamrmd at it again

Gautam Rangavajla

@gautamrmd

1 year

Incredibly grateful to the opportunities provided by @HviUpmc over the last 3 years. Thanks to @AdityaBhonsale and @drtalhakhawaja for their mentorship and support with this project and #hrs2023 for the invitation to present!! Pic credit: @MehakDhande

3

27

0

6

Andy Knight

@AndyKnightMD

1 year

Perfect timing for this excellent panel on presenting yourself with @ShikhaJainMD @StephenVLiu @IlanaSchlam @RManochakian #ASCO23

0

3

6

Andy Knight

@AndyKnightMD

1 year

Such a nice bonus of #AIMW23 to be able to see all these wonderful people again!

Molly Frost

@MollyFrostMD

1 year

Ran into a bunch of soon-to-be Chief Residents from UCCOM Class of 2020 at #AIMW23 ! @UCincyMedicine @coberll

2

4

47

0

5

Andy Knight

@AndyKnightMD

2 years

In 2011 ipilimumab became the first immune checkpoint inhibitor (ICI) to be approved for the treatment of advanced melanoma after demonstrating improved overall survival compared to chemotherapy. We explore the timeline of ICIs since then highlighting keynote trials.

1

0

5

Andy Knight

@AndyKnightMD

2 years

@gautamrmd @AdityaBhonsale Congratulations! Well deserved

0

5

Andy Knight

@AndyKnightMD

1 year

So well deserved! Looking forward to all the amazing work you'll do @MayoHemeOnc

0

4

Andy Knight

@AndyKnightMD

2 years

Thank you to @jmkirkwood and @KarapetLilit for the support and guidance in writing this review.

0

3

Andy Knight

@AndyKnightMD

2 years

Adoptive cell therapy is a cellular immunotherapy produced with ex vivo expansion of tumor infiltrating lymphocytes. The anti-tumor immunity of these lymphocytes is then further stimulated with IL-2 after administration. We highlight recent ACT trials in melanoma

1

0

3

Andy Knight

@AndyKnightMD

2 years

Despite the efficacy of ICIs, not all patients respond. There is an ongoing need for therapies for patients refractory IO. We highlight several of these.

1

0

3

Andy Knight

@AndyKnightMD

9 months

@JZarkaMD @MayoHemeOnc @JessicaAtieh @PittGIM @PittIMChiefs @pbulova @GhayasIssa @YanaNajjarMD @MayoClinic @jonaspaludo @VictorChedidMD Power couple! So happy for you both! Well deserved 🎉🎉🎉

0

3

Andy Knight

@AndyKnightMD

2 years

There has been considerable interest in neoadjuvant immunotherapy as a way to activate in situ tumor-infiltrating lymphocytes for greater anti-tumor immune response. We cover the results of SWOG 1801 from @DrSapnaPatel , et al. showing the potential of a neoadjuvant approach.

1

0

3

Andy Knight

@AndyKnightMD

9 months

@HamandiMd @MayoClinic @MayoCVFellows @PittIMChiefs @PittGIM Congratulations Moe! So happy for you. Youre going to do amazing things there! 🎉🎉🎉

1

0

2

Andy Knight

@AndyKnightMD

2 years

@HMAbushukair @AnwaarSaeed3 @KarapetLilit @HadidiSamer @FawziAbuRous Great work Hassan! Truly well deserved

1

0

2

Andy Knight

@AndyKnightMD

9 months

@LewisWu19 @DanaFarber @KarapetLilit @jmkirkwood @YanaNajjarMD @LenAppleman @jasonlukemd You are going to be a rockstar at UW! Can't wait to see all the incredible things you do 🎉🎉🎉

0

2

Andy Knight

@AndyKnightMD

2 years

STING agonists and TLR-9 agonists may have synergistic activity ICIs - trials currently underway.

1

0

2

Andy Knight

@AndyKnightMD

2 years

@JZarkaMD @PittIMChiefs @UPMCHillmanCC @PittHemeOnc @ASH_hematology @PittGIM @KonLontos I think I see @AseelSoqi in the back! Looks like a great #ASH22 crew

0

2

Andy Knight

@AndyKnightMD

1 year

@PittGIM @ACarterMD Congratulations @ACarterMD 🎉 We couldn't ask for a better leader!

0

2

Andy Knight

@AndyKnightMD

1 year

@LDiamantMD @PGrivasMDPhD @JLWrightMD @Korentzelos @PittGIM @PittIMChiefs @urotoday @Uromigos @UrolOncol @DMakrakisMD Great work Leo!

0

1

Andy Knight

@AndyKnightMD

2 years

@gautamrmd @PriSolankiMD @PittDeptofMed @MehakDhande @saba_sfs3 @DavidNewhouse37 @HamandiMd Great work looking at the impact of GDMT on ICD placement for patients with heart failure! Looking forward to seeing more results in the future.

0

2

Andy Knight

@AndyKnightMD

7 months

@RandolphLydePhD @PittHemeOnc @PittIMChiefs Congratulations Randy! So happy for you!

0

1

Andy Knight

@AndyKnightMD

1 year

@AseelSoqi Congratulations Aseel! Well deserved

1

0

2

Andy Knight

@AndyKnightMD

2 years

Fecal microbiotia transplantation was shown by @diwakardavar et al. to have a the potential to convert ICI non responders to responders.

1

2

Andy Knight

@AndyKnightMD

1 year

@NadeenSarsour @PittGILiverNutr @PittGIM @PittIMChiefs @Cindytraboulsi What a crew! Congratulations 👏

0

2

Andy Knight

@AndyKnightMD

1 year

@MSharpMed @PittDeptofMed @PittIMChiefs @JeredSharp Amazing! Congratulations, we are so happy to have to join us!

1

0

2

Andy Knight

@AndyKnightMD

1 year

@LizCifuentesMD Congratulations! This is exactly the kind of work we need to understand how to guide these patients

0

2

Andy Knight

@AndyKnightMD

1 year

@kseniya_y_a @PittIMChiefs Congratulations and welcome! We are so happy to have you join us

1

0

1

Andy Knight

@AndyKnightMD

1 year

@AntoineBejjani_ @AminNassarMD @MrouehNayla @PittGIM @PittIMChiefs @bbikdeli Congratulations to you and your wife! We are so excited for you to join us in Pittsburgh!

1

0

1

Andy Knight

@AndyKnightMD

1 year

@MSharpMed @ACPIMPhysicians @FutureDrFab @zachreuter Wow! Congratulations 🎉

0

1

Andy Knight

@AndyKnightMD

2 years

@PittGIM @IradaChoudhuri Great work Irada!

0

1

Andy Knight

@AndyKnightMD

1 year

@HMAbushukair @JIPOEditors @AnwaarSaeed3 Great work Hassan!

1

0

1

Andy Knight

@AndyKnightMD

11 months

@gmvasilakis Rockstar! 🙌

0

1

Andy Knight

@AndyKnightMD

1 year

@HMAbushukair @jmkirkwood @KarapetLilit @UPMCHillmanCC Thank you for your valuable contributions to this work Hassan!

1

0

1

Andy Knight

@AndyKnightMD

2 years

@JZarkaMD @PittHemeOnc @PittIMChiefs @UPMCHillmanCC @ASH_hematology Great work Jabra!

1

0

1

Andy Knight

@AndyKnightMD

1 year

@AdamEibel @PittGIM @PittIMChiefs @UPMCAnesRes Congratulations to both of you! We're so happy you will be staying with us!

1

0

1

Andy Knight

@AndyKnightMD

1 year

@gautamrmd @HviUpmc @AdityaBhonsale @drtalhakhawaja @MehakDhande Congratulations 🎉

0

1

Andy Knight

@AndyKnightMD

1 year

@CarolineKetter2 @PittDermatology Amazing Caroline! You deserve it!

0

1

Andy Knight

@AndyKnightMD

1 year

@TarekHaykal1 @ASCO Great list! Looking forward to all of these

0

1

Andy Knight

@AndyKnightMD

1 year

@isa_tz @UPMC @PittIMChiefs @TheNRMP Congratulations and welcome to the program!

0

1

Andy Knight

@AndyKnightMD

1 year

@Ronaldo_CFF @CardioNerds Congratulations Ronnie! Looks like a great project

0

1

Andy Knight

@AndyKnightMD

2 years

Happy to be presenting and excited to see the results of such amazing work from my coresidents!

PittDeptofMed

@PittDeptofMed

2 years

🗓️ Join us at noon on Tuesday, 09.20.22, for the next DOM Grand Rounds! Tuesday's talk will feature research presentations from five internal medicine residents. For the link, visit .

0

5

0

1

Andy Knight

@AndyKnightMD

1 year

@HMAbushukair Congratulations Hassan! So glad you were able to present this work

1

0

1

Andy Knight

@AndyKnightMD

2 years

@saaaaaarrrrrrr When I applied I used a dedicated email for applications and an app that would alarm for any email that account received even if my phone was on silent. Everyone else feels the pressure too though trust me!

1

0

1

Andy Knight

@AndyKnightMD

1 year

@liyan_fan14 @UPMC @PittDeptofMed @davidr_sweet @PittGIM @PittIMChiefs Congratulations and welcome! So happy you are both joining us!

0

1

Andy Knight

@AndyKnightMD

2 years